Aspen Neuroscience, the company founded in 2018 by Dr. Jeanne Loring to bring her research to market, has raised $70 million in funding, which will be used to complete the work required for FDA approval and initiation of a clinical trial. The company plans to treat the symptoms of Parkinson’s disease by replacing the lost dopamine neurons with autologous (DNA-matching) dopamine neurons created from the person’s own cells.
Slowly but Surely, the USA Inches Toward ... - Cure Parkinson's
Slowly but Surely, the USA Inches Toward Stem Cell Trials
Written by
jimcaster
To view profiles and participate in discussions please or .
Read more about...
3 Replies
•
Let's hope this gets going soon. One of the most promising areas of research
internationalstemcell.com/c...
You forget wha happens outside the US Jim
Not what you're looking for?
You may also like...
Aspen FINALLY Moving forward with Stem Cell Trials
repeatedly writing posts regarding Dr. Jeanne Loring, Aspen Neuroscience, and/or stem cell trials...
Pioneering stem-cell trials in Japan report promising early results
brains of seven people with Parkinson’s disease between 2018 and 2021. Takahashi says that no...
Update on Japanese stem cell trial
clinical trial of cell transplantation for Parkinson's disease, we have completed all seven...
Hope Biosciences Stem Cell Trial
also in trial of mesenchymal stem cells for Parkinson's at Hope Biosciences, please send me a...